Bayer to buy AskBio for $2B in bid to become a gene therapy player

Bayer has agreed to acquire Asklepios Biopharmaceuticals, a privately held gene therapy developer formed nearly two decades ago by one of the field's pioneers, University of North Carolina researcher Jude Samulski.